[1] Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression [J]. Brain, behavior, and immunity,2011, 25(2): 221-229. [2] Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression[J]. Progress in neuro-psychopharmacology & biological psychiatry,2011, 35(3): 664-675. [3] Raison CL, Dantzer R, Kelley KW,et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression [J]. Molecular psychiatry,2010, 15(4): 393-403. [4] Muller N, Myint AM, Schwarz MJ. Inflammatory biomarkers and depression[J]. Neurotoxicity research,2011, 19(2): 308-318. [5] Udina M, Moreno-Espana J, Capuron L,et al. Cytokine-induced depression: current status and novel targets for depression therapy [J].cnS & neurological disorders drug targets,2014, 13(6): 1066-1074. [6] Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis[J]. Psychosomatic medicine,2009, 71(2): 171-186. [7] Beaujean AA, Parker S, Qiu X. The relationship between cognitive ability and depression: a longitudinal data analysis[J]. Social psychiatry and psychiatric epidemiology,2013, 48(12): 1983-1992. [8] Morimoto SS, Alexopoulos GS. Immunity, aging, and geriatric depression[J]. The Psychiatric clinics of North America,2011, 34(2): 437-449. [9] Hidaka S, Ikejima C, Kodama C,et al. Prevalence of depression and depressive symptoms among older Japanese people: comorbidity of mild cognitive impairment and depression [J]. International journal of geriatric psychiatry,2012, 27(3): 271-279. [10] Craddock D, Thomas A. Cytokines and late-life depression[J]. Essential psychopharmacology,2006, 7(1): 42-52. [11] Musselman D, Royster EB, Wang M,et al. The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings [J]. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology,2013, 38(10): 1921-1928. |